Cargando…

Basic and Clinical Advances in Chronic Liver Inflammation

Detalles Bibliográficos
Autores principales:	Enomoto, Hirayuki, Tamori, Akihiro, Yoshiji, Hitoshi, Seki, Ekihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783579/ https://www.ncbi.nlm.nih.gov/pubmed/27006527 http://dx.doi.org/10.1155/2016/1571457

Ejemplares similares

Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets
por: Kim, Jieun, et al.
Publicado: (2023)

Acrolein, a New Villain in the Development of Alcoholic Liver Disease
por: Seki, Ekihiro
Publicado: (2016)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2023)

Nuclear Receptors: Opening Up New Avenues of Pediatric Fatty Liver Research
por: Pandyarajan, Vijay, et al.
Publicado: (2018)

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
por: Tamori, Akihiro, et al.
Publicado: (2016)

Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era
por: Kanda, Tatsuo, et al.
Publicado: (2022)

Intestinal Lipolysis Mitigates Nonalcoholic Fatty Liver Disease: New Roles for Carboxylesterase 2c in the Intestine
por: Pimienta, Michael, et al.
Publicado: (2019)

Toll-Like Receptor Signaling in Liver Diseases
por: Szabo, Gyongyi, et al.
Publicado: (2010)

Tumor Suppressor Down-Regulation Promotes Hepatocyte Proliferation: A New GANKster on the Block
por: Pimienta, Michael, et al.
Publicado: (2018)

Crossing the Rubicon: Adipose Tissue Autophagy Breaks Out NAFLD
por: Kim, Jieun, et al.
Publicado: (2021)

Kupffer Cell TLR2/3 Signaling: A Pathway for EGCG Amelioration of Ethanol-Induced Hepatic Injury
por: Czech, Torrey Y., et al.
Publicado: (2019)

Alcoholic liver disease: A current molecular and clinical perspective()
por: Ohashi, Koichiro, et al.
Publicado: (2018)

TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis
por: Seki, Ekihiro
Publicado: (2014)

Acute-on-Chronic Liver Failure: From Basic Research to Clinical Applications
por: Chen, En-Qiang, et al.
Publicado: (2018)

A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1
por: Czech, Torrey Y., et al.
Publicado: (2018)

Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms
por: Yang, Ling, et al.
Publicado: (2012)

TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis
por: Wang, Weijun, et al.
Publicado: (2021)

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
por: Lee, Young-Sun, et al.
Publicado: (2023)

Basic and Clinical Advances in the Diagnosis and Management of Migraine
por: Shi, Xiaolei, et al.
Publicado: (2020)

Frailty and Sleep Disorder in Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Toll-Like Receptor Signaling and Liver Fibrosis
por: Aoyama, Tomonori, et al.
Publicado: (2010)

Metabolism, inflammation, and cardiovascular diseases from basic research to clinical practice
por: Huang, Zihang, et al.
Publicado: (2023)

Natural Products for Liver Diseases: Basic, Clinical, and Translational Research
por: Ling, Chang-Quan, et al.
Publicado: (2012)

Basic and Translational Advances in Glioblastoma
por: Piccirillo, Sara G. M., et al.
Publicado: (2018)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Basic Experimental and Clinical Advances in the Mechanisms Underlying Abnormal Pregnancy Outcomes
por: Regnault, Timothy R. H., et al.
Publicado: (2013)

Advances in Urological Cancer in 2022, from Basic Approaches to Clinical Management
por: Manini, Claudia, et al.
Publicado: (2023)

Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis
por: Fujii, Hideki, et al.
Publicado: (2021)

Recent Advances in Obesity-Induced Inflammation and Insulin Resistance
por: Tateya, Sanshiro, et al.
Publicado: (2013)

Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4
por: Kim, Sun Myoung, et al.
Publicado: (2022)

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2010)

Basics, Epidemiology, Diagnosis, and Management of Liver Tumor
por: Abe, Hiroyuki, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease: from basic research to clinical application
por: Yang, Ruixu, et al.
Publicado: (2022)

Desmosomes and Desmosomal Cadherin Function in Skin and Heart Diseases—Advancements in Basic and Clinical Research
por: Mahoney, Mỹ G., et al.
Publicado: (2010)

Hepatitis B virus infection and alcohol consumption
por: Iida-Ueno, Ayako, et al.
Publicado: (2017)

Breast cancer liver metastasis: Pathogenesis and clinical implications
por: Liu, Cuiwei, et al.
Publicado: (2022)

Risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients–Relationship to smoking and alcohol
por: Matsuura, Tomoka, et al.
Publicado: (2020)

The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B
por: Suoh, Maito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_56l6p1v55301nj1ust9o9lpq9v